CVE-2023-26451

Functions with insufficient randomness were used to generate authorization tokens of the integrated oAuth Authorization Service. Authorization codes were predictable for third parties and could be use ...

Continue Reading

CVSS3 - HIGH

CVSS2 - MEDIUM

CVE-2023-34196

In the Keyfactor EJBCA before 8.0.0, the RA web certificate distribution servlet /ejbca/ra/cert allows partial denial of service due to an authentication issue. In configurations using OAuth, disclosu ...

Continue Reading

CVSS3 - HIGH

CVSS2 - MEDIUM

CVE-2023-35064

Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in Satos Satos Mobile allows SQL Injection through SOAP Parameter Tampering.This issue affects Satos ...

Continue Reading

CVSS3 - CRITICAL

CVSS2 - HIGH

CVE-2023-34960

A command injection vulnerability in the wsConvertPpt component of Chamilo v1.11.* up to v1.11.18 allows attackers to execute arbitrary commands via a SOAP API call with a crafted PowerPoint name.Read ...

Continue Reading

CVSS3 - CRITICAL

CVSS2 - HIGH

CVE-2023-2534

Improper Authorization vulnerability in OTRS AG OTRS 8 (Websocket API backend) allows any as Agent authenticated attacker to track user behaviour and to gain live insight into overall system usage. Us ...

Continue Reading

CVSS3 - HIGH

CVSS2 - MEDIUM

CVE-2023-3581

Mattermost fails to properly validate the origin of a websocket connection allowing a MITM attacker on Mattermost to access the websocket APIs.Read More ...

Continue Reading

CVSS3 - HIGH

CVSS2 - MEDIUM

CVE-2023-29505

An issue was discovered in Zoho ManageEngine Network Configuration Manager 12.6.165. The WebSocket endpoint allows Cross-site WebSocket hijacking.Read More ...

Continue Reading

CVSS3 - HIGH

CVSS2 - MEDIUM

CVE-2023-29863

Medical Systems Co. Medisys Weblab Products v19.4.03 was discovered to contain a SQL injection vulnerability via the tem:statement parameter in the WSDL files.Read More ...

Continue Reading

CVSS3 - CRITICAL

CVSS2 - HIGH

Back to Main

Subscribe for the latest news: